May 4, 2022

Valeura Energy to deliver increased production and increased cash flow going forward (LON:VLU)

Valeura Energy plc (LON:VLU) Chief Executive Officer Sean Guest up with DirectorsTalk for an exclusive interview to discuss their recent acquisition of KrisEnergy’s Thai assets, expected contribution to revenues, significant..

Fidelity European Trust delivers long-term outperformance against its benchmarks says Hardman & Co (LON:FEV)

Fidelity European Trust plc (LON:FEV) is the topic of conversation when Hardman and Co’s Investment Companies Analyst Riccardo Bindi caught up with DirectorsTalk for an exclusive interview. Q1: What can..

Egdon Resources continued strong production and revenues (LON:EDR)

Egdon Resources plc (LON:EDR) Managing Director Mark Abbott caught up with DirectorsTalk for an exclusive interview to discuss half year results, exceeding expectations at Wressle, the government’s review of shale..

Ferro-Alloy Resources profitability boosted by by-product credits, says Liberum

Ferro-Alloy Resources (LON:FAR) is the topic of conversation when DirectorsTalk MD, Darren Turgel, caught up with Yuen Low, Equity Research Analyst, at Liberum. Q1. What are the key highlights from..

Fidelity Japan Trust, Analyst thoughts on performance and markets for AGM (Analyst VIDEO)

Fidelity Japan Trust Plc (LON:FJV) is the topic of conversation when Hardman & Co Analyst Mark Thomas joins DirectorsTalk Interviews. Mark talks us through his latest report entitled ‘FJV: 10..

Union Jack Oil Wressle gives significant optionality going forward

Union Jack Oil plc (LON:UJO) is the topic of conversation when DirectorsTalk MD Darren Turgel caught up with Dan Slater, Arden Partners Head of Energy. Union Jack has released a..

Flutter Entertainment delivers a positive Q1 performance with revenue growth of 6%

Flutter Entertainment plc (LON:FLTR) has announced a trading update for three months ended 31 March 2022. Unaudited £m Q1 2022 Q1 2021 YoY % YoY % CC1 Average monthly players2 (‘000s) 8,855 7,672..

AstraZeneca’s Imfinzi sBLA accepted and granted Priority Review in the US

AstraZeneca plc (LON:AZN) supplemental Biologics License Application (sBLA) for Imfinzi (durvalumab), in combination with standard-of-care chemotherapy, has been accepted and granted Priority Review in the US for patients with locally..

DF Capital appoints two new Non-Executive Directors

Distribution Finance Capital Holdings plc (LON:DFCH), the specialist bank providing working capital solutions to dealers and manufacturers across the UK, today announces the following Board changes, subject to regulatory approval:..

Renold appoints Vicki Potter as a Non-Executive Director

Renold plc (LON:RNO), a leading international supplier of industrial chains and related power transmission products, has announced the appointment of Victoria (Vicki) Potter to the Company’s Board as a Non-Executive..

Inchcape continues to see robust consumer demand says Zeus

Inchcape plc (LON:INCH) Q1 trading update last week showed a strong start to the year, with revenue up 13% organically vs. Q1 2021. We upgrade our FY22 underlying PBT forecast..

‘Significant upside from current trading level’ of Goodbody Health says Arden analyst

Goodbody Health Inc. is the topic of conversation when DirectorsTalk Interviews Managing Director Darren Turgel caught up with Colin Smith, Director of Equity Research at Arden & Partners. What has..

Ilika plc Goliath scale-up plans validated

Ilika plc (LON:IKA), a pioneer in solid-state battery technology, has announced the successful conclusion of its scale-up study, SOLSTICE, with partner Comau, part of Stellantis, and a world leader in..

boohoo group total group sales +61% since FY2020

boohoo group plc (LON:BOO) have today published final results for the year ended 28th February 2022. Investing for the future ·    Significantly increased market share in the UK and US since..

Open Orphan no plans to delist, substantial contract with existing top 5 global pharmaceutical client

Comment re: speculation Open Orphan plc (LON:ORPH), a rapidly growing specialist contract research organisation (CRO) and world leader in testing infectious and respiratory disease products using human challenge clinical trials,..

Actual Experience employees and Directors buy shares in company

Actual Experience plc (AIM: ACT), the analytics-as-a-service company, has confirmed that it has issued 28,675 new ordinary shares of 0.2p each in the capital of Actual Experience, under the terms..

Search

Funds

May 4, 2022

Search

Funds

May 4, 2022

FTSE 100

Funds